ASTELLAS PHARMA EUROPE B.V.

Advagraf is an immunosuppressant used in adults after an organ transplant (such as liver or kidney) to control the immune response and prevent the body from rejecting the transplanted organ. It can also be used in cases of ongoing rejection.

Dosage form: capsules, hard gelatin, extended release

ATC: L04AD02

The medicine is used to treat the symptoms of an overactive bladder in adults (such as urgency to urinate, increased frequency, and incontinence) and to treat neurogenic detrusor overactivity in children aged 3 to 18 years, helping them to hold more urine and reduce leakage.

Dosage form: tablets, prolonged-release

ATC: G04BD12

It is used to treat adults with symptomatic anemia caused by chronic kidney disease. It helps to increase the number of red blood cells and hemoglobin levels in the blood.

Dosage form: tablets, film-coated

ATC: B03XA05

Modigraf is an immunosuppressant used in adults and children after an organ transplant (such as liver, kidney, or heart) to control the immune response and prevent rejection of the transplanted organ. It can also be used to treat an ongoing rejection.

Dosage form: granules for oral suspension

ATC: L04AD02

It is used in adults to treat a type of cancer called bladder cancer (urothelial cancer), when the tumor has spread or cannot be surgically removed. It can be used alone or in combination with pembrolizumab.

Dosage form: powder for concentrate for injectable/infusion solution

ATC: L01FX13

It is used by menopausal women to reduce moderate to severe vasomotor symptoms, such as hot flashes and night sweats.

Dosage form: tablets, film-coated

ATC: G02CX06

This medicinal product is used to treat adult patients with gastric cancer or gastro-oesophageal junction cancer (the point where the oesophagus meets the stomach), when the tumour cannot be surgically removed or has spread to other parts of the body. It is administered to patients whose tumours are positive for the Claudin 18.2 protein and negative for the HER2 protein.

Dosage form: powder for concentrate for infusion solution

ATC: L01FX31

It is used for the treatment of adults with acute myeloid leukemia (AML), a type of cancer that affects white blood cells, specifically when the disease is associated with a FLT3 gene mutation and has recurred or has not improved after other treatments.

Dosage form: tablets, film-coated

ATC: L01EX13

It is used for the treatment of adult men with prostate cancer that no longer responds to hormonal or surgical therapy, which has spread to other parts of the body, or who show a rapid increase in PSA after previous prostate removal or radiotherapy.

Dosage form: capsules, soft gelatin

ATC: L02BB04